Kronos Bio, Inc.

KRON · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$86-$113-$133-$151
Dep. & Amort.$2$2$2$2
Deferred Tax$0$0$0$4
Stock-Based Comp.$9$25$31$26
Change in WC-$18$6$6-$2
Other Non-Cash$28$1$3$3
Operating Cash Flow-$65-$79-$91-$118
Investing Activities
PP&E Inv.-$0-$1-$1-$4
Net Acquisitions$0$0$32-$68
Inv. Purchases-$89-$213-$367-$178
Inv. Sales/Matur.$175$280$335$246
Other Inv. Act.$0$0-$32$68
Investing Cash Flow$85$66-$32$64
Financing Activities
Debt Repay.$0$0$0-$0
Stock Issued$0$1$1$4
Stock Repurch.$0$1$0$1
Dividends Paid$0$0$0$0
Other Fin. Act.$0$1$1$4
Financing Cash Flow$0$1$1$4
Forex Effect$0$0$0$0
Net Chg. in Cash$20-$12-$122-$50
Supplemental Information
Beg. Cash$66$78$200$250
End Cash$87$66$78$200
Free Cash Flow-$65-$79-$92-$122